-
PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and Therapy.
17 May 2024 15:24 GMT
Prostate cancer (PCa) is the most common … H. Morgan Department of Radiology, Johns Hopkins University School of Medicine, Baltimore …
-
Determinants of receipt of prostate cancer screening among men living with HIV enrolled in an urban HIV Clinic in the United States over the period of 2000-2020.
14 May 2024 07:16 GMT
… determinants of PSA test as prostate cancer screening guidelines changed.
Men (n … Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, United States., … Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, United States. …
-
Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED).
02 May 2024 07:59 GMT
… men with metastatic hormone-sensitive prostate cancer (mHSPC). However, the prognostic … men with metastatic hormone-sensitive prostate cancer in the CHAARTED study. … and Clinics, Madison, WI, USA., Johns Hopkins University, Baltimore, MD, USA., University …
-
Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey-Holden Prostate Cancer Academy Meeting.
30 Apr 2024 08:40 GMT
… to cure metastatic prostate cancer without castration, reducing prostate cancer morbidity and … Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore … Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, …
-
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer.
24 Apr 2024 08:24 GMT
… enrolled participants with advanced prostate cancer treated with PARP inhibitors. … Antonarakis
Department of Oncology, Johns Hopkins University School of Medicine, … Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, …
-
Smart nanoprobe illuminates prostate cancer cells, reveals research
23 Apr 2024 00:23 GMT
… Johns Hopkins University have developed a smart nanoprobe designed to infiltrate prostate tumors …
The researchers used two prostate cancer cell lines exhibiting varying levels … care for men afflicted with prostate cancer,” explained Tatjana Atanasijevic, Ph …
-
RECIP 1.0 Predicts Progression-Free Survival After [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.
22 Apr 2024 10:29 GMT
… therapeutic efficacy in metastatic prostate cancer using prostate-specific membrane … Radiology and Radiological Science, Johns Hopkins University School of Medicine, … Radiology and Radiological Science, Johns Hopkins University School of Medicine, …
-
Dietary Fiber Intake and Risk of Advanced and Aggressive Forms of Prostate Cancer: A Pooled Analysis of 15 Prospective Cohort Studies.
22 Apr 2024 10:29 GMT
… advanced and aggressive forms of prostate cancer (PC) and PC mortality is … Center., Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health …
-
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.
19 Apr 2024 10:04 GMT
Benefits of prostate cancer (PCa) screening with prostate-specific … , including serum PSA alone, the Prostate Cancer Prevention Trial risk calculator, and … ., Departments of Pathology and Urology, Johns Hopkins University School of Medicine, Baltimore …
-
Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome.
18 Apr 2024 08:59 GMT
… with an increased risk of prostate cancer (PCa). Since 2010 we have … , Trondheim, Norway., Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland, USA., Department …